Approval · Notice of Compliance 25301 · 2021
METADOL-D: Notice of Compliance 25301
Issued February 26, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25301
- Date
- February 26, 2021
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To apply the advisory letter dated july 17, 2020
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METADOL-D | 02247696 | Cancelled Pre Market |
| METADOL-D | Not yet assigned | — |
Medicinal ingredients
- METHADONE HYDROCHLORIDE 1 MG per ML
- METHADONE HYDROCHLORIDE 10 MG per ML
- METHADONE HYDROCHLORIDE 1 MG per TAB
- METHADONE HYDROCHLORIDE 5 MG per TAB
- METHADONE HYDROCHLORIDE 10 MG per TAB
- METHADONE HYDROCHLORIDE 25 MG per TAB